TSX runs higher on rate cut expectations
Investing.com - Benchmark maintained its Buy rating and $32.00 price target on IMAX Corporation (NYSE:IMAX) on Wednesday. The stock, currently trading at $27.74 and near its 52-week high of $29.66, has shown strong momentum with a 7.73% gain in the past week. According to InvestingPro data, three analysts have recently revised their earnings estimates upward for the upcoming period.
The research firm noted that IMAX is positioned to exceed third-quarter expectations, with global box office already reaching approximately $240 million and trending toward surpassing the consensus estimate of $286 million for Q3 2025.
Benchmark expressed confidence in IMAX’s quarterly performance potential, citing positive slate momentum and strong indexing trends that help mitigate execution risk.
The firm highlighted that the IMAX brand continues to resonate with consumers, driving sustained market share gains and establishing IMAX as the premium platform for both blockbuster and local-language cinema.
Benchmark pointed to strong visibility into what it called a "record Q4 slate" and "unprecedented studio alignment" extending into 2026 and beyond as compelling evidence for continued global screen growth and network expansion.
In other recent news, IMAX Corporation has reported significant developments across various aspects of its business. The company announced that Warner Bros./DC Studios’ "Superman" achieved a $30.4 million global debut in IMAX theaters, with $19.1 million coming from North America. This represents the highest IMAX market share ever for a film opening above $100 million domestically. Additionally, IMAX has expanded its credit facility from $300 million to $375 million, with an option to increase it to $515 million, maturing in 2030. The agreement was made with a syndicate of seven lenders, including Wells Fargo Securities, LLC as the lead arranger.
IMAX also revealed plans to return to Philadelphia in 2026, partnering with Apple Cinemas to install five IMAX with Laser systems across the United States. This includes a new location at Riverview Plaza, set to become the largest cinema in Philadelphia’s Center City. In Australia, IMAX has rekindled its partnership with HOYTS Cinemas, planning to open up to five new theaters, with the first scheduled to open in Melbourne in 2025. Meanwhile, Benchmark has maintained a Buy rating on IMAX stock, highlighting the company’s growing influence in the premium format market despite potential competition from other theater chains.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.